On December 18, 2012, I published a Seeking Alpha article naming Cellceutix (OTCQB:CTIX) as my Stock of the Year for 2013. Six months into the year, let's take an updated look why CTIX is still my 2013 Stock of the Year.
The recent offer by Amgen (NASDAQ: AMGN) to buy Onyx Pharmaceuticals (NASDAQ: ONXX) is the latest in a string of acquisitions that has cancer drug makers on the hot list again. Effective oncology drugs can command a premium like no other, which is why I maintain an extremely bullish stance on Cellceutix as one of the most compelling biotechnology companies today and for the future. Shares have spiked to deliver gains as high as 150...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|